Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

Clinical trial NCT07247162 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07247162
Sponsor: RECORDATI GROUP
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension Hypercortisolemia Cushing Syndrome

Start date: 2026-08-01
Primary completion: 2028-05-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.